COVID-19 Resources for Blood Donor Centers
Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
AstraZeneca Withdraws Factor Xa Reversal Agent From US Market
December 23, 2025
FDA Eases Access to Real-World Evidence in Drug and Device Reviews
December 16, 2025
REGULATORY UPDATE: ‘Ask the FDA and CMS/CLIA' 2025 Annual Meeting Slides Now Available
December 15, 2025